The result showed that IL-17A expression did not correlate to patients’ age, FIGO stage, and tumor size, while IL-17A expression was significantly correlated to patients’ invasion depth and lymphatic metastasis status (P<0.01, students t-test, Table 1). This evidence concerns the gene IL17A and neoplasm.